Spatial genomic heterogeneity within localized, multifocal prostate cancer - PubMed (original) (raw)
doi: 10.1038/ng.3315. Epub 2015 May 25.
Michael Fraser 2, Nicholas J Harding 3, Richard de Borja 3, Dominique Trudel 4, Emilie Lalonde 5, Alice Meng 6, Pablo H Hennings-Yeomans 3, Andrew McPherson 7, Veronica Y Sabelnykova 3, Amin Zia 3, Natalie S Fox 5, Julie Livingstone 3, Yu-Jia Shiah 3, Jianxin Wang 3, Timothy A Beck 3, Cherry L Have 4, Taryne Chong 3, Michelle Sam 3, Jeremy Johns 3, Lee Timms 3, Nicholas Buchner 3, Ada Wong 3, John D Watson 3, Trent T Simmons 3, Christine P'ng 3, Gaetano Zafarana 2, Francis Nguyen 3, Xuemei Luo 3, Kenneth C Chu 3, Stephenie D Prokopec 3, Jenna Sykes 8, Alan Dal Pra 9, Alejandro Berlin 9, Andrew Brown 3, Michelle A Chan-Seng-Yue 3, Fouad Yousif 3, Robert E Denroche 3, Lauren C Chong 3, Gregory M Chen 3, Esther Jung 3, Clement Fung 3, Maud H W Starmans 3, Hanbo Chen 3, Shaylan K Govind 3, James Hawley 3, Alister D'Costa 3, Melania Pintilie 8, Daryl Waggott 3, Faraz Hach 7, Philippe Lambin 10, Lakshmi B Muthuswamy 3, Colin Cooper 11, Rosalind Eeles 12, David Neal 13, Bernard Tetu 14, Cenk Sahinalp 7, Lincoln D Stein 3, Neil Fleshner 15, Sohrab P Shah 16, Colin C Collins 17, Thomas J Hudson 3, John D McPherson 3, Theodorus van der Kwast 4, Robert G Bristow 18
Affiliations
- PMID: 26005866
- DOI: 10.1038/ng.3315
Spatial genomic heterogeneity within localized, multifocal prostate cancer
Paul C Boutros et al. Nat Genet. 2015 Jul.
Abstract
Herein we provide a detailed molecular analysis of the spatial heterogeneity of clinically localized, multifocal prostate cancer to delineate new oncogenes or tumor suppressors. We initially determined the copy number aberration (CNA) profiles of 74 patients with index tumors of Gleason score 7. Of these, 5 patients were subjected to whole-genome sequencing using DNA quantities achievable in diagnostic biopsies, with detailed spatial sampling of 23 distinct tumor regions to assess intraprostatic heterogeneity in focal genomics. Multifocal tumors are highly heterogeneous for single-nucleotide variants (SNVs), CNAs and genomic rearrangements. We identified and validated a new recurrent amplification of MYCL, which is associated with TP53 deletion and unique profiles of DNA damage and transcriptional dysregulation. Moreover, we demonstrate divergent tumor evolution in multifocal cancer and, in some cases, tumors of independent clonal origin. These data represent the first systematic relation of intraprostatic genomic heterogeneity to predicted clinical outcome and inform the development of novel biomarkers that reflect individual prognosis.
Comment in
- Prostate cancer: Intrapatient heterogeneity in prostate cancer.
Beltran H, Demichelis F. Beltran H, et al. Nat Rev Urol. 2015 Aug;12(8):430-1. doi: 10.1038/nrurol.2015.182. Epub 2015 Jul 28. Nat Rev Urol. 2015. PMID: 26215693 No abstract available.
Similar articles
- Spatial Intratumor Genomic Heterogeneity within Localized Prostate Cancer Revealed by Single-nucleus Sequencing.
Su F, Zhang W, Zhang D, Zhang Y, Pang C, Huang Y, Wang M, Cui L, He L, Zhang J, Zou L, Zhang J, Li W, Li L, Shao J, Ma J, Xiao F, Liu M. Su F, et al. Eur Urol. 2018 Nov;74(5):551-559. doi: 10.1016/j.eururo.2018.06.005. Epub 2018 Jun 23. Eur Urol. 2018. PMID: 29941308 - Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level.
Rangel-Pozzo A, Liu S, Wajnberg G, Wang X, Ouellette RJ, Hicks GG, Drachenberg D, Mai S. Rangel-Pozzo A, et al. Cells. 2020 Aug 8;9(8):1863. doi: 10.3390/cells9081863. Cells. 2020. PMID: 32784507 Free PMC article. - Genetic markers associated with early cancer-specific mortality following prostatectomy.
Liu W, Xie CC, Thomas CY, Kim ST, Lindberg J, Egevad L, Wang Z, Zhang Z, Sun J, Sun J, Koty PP, Kader AK, Cramer SD, Bova GS, Zheng SL, Grönberg H, Isaacs WB, Xu J. Liu W, et al. Cancer. 2013 Jul 1;119(13):2405-12. doi: 10.1002/cncr.27954. Epub 2013 Apr 22. Cancer. 2013. PMID: 23609948 Free PMC article. - The genomic evolution of human prostate cancer.
Mitchell T, Neal DE. Mitchell T, et al. Br J Cancer. 2015 Jul 14;113(2):193-8. doi: 10.1038/bjc.2015.234. Epub 2015 Jun 30. Br J Cancer. 2015. PMID: 26125442 Free PMC article. Review. - Genomic and phenotypic heterogeneity in prostate cancer.
Haffner MC, Zwart W, Roudier MP, True LD, Nelson WG, Epstein JI, De Marzo AM, Nelson PS, Yegnasubramanian S. Haffner MC, et al. Nat Rev Urol. 2021 Feb;18(2):79-92. doi: 10.1038/s41585-020-00400-w. Epub 2020 Dec 16. Nat Rev Urol. 2021. PMID: 33328650 Free PMC article. Review.
Cited by
- Machine learning-based cell death marker for predicting prognosis and identifying tumor immune microenvironment in prostate cancer.
Gao F, Huang Y, Yang M, He L, Yu Q, Cai Y, Shen J, Lu B. Gao F, et al. Heliyon. 2024 Sep 6;10(18):e37554. doi: 10.1016/j.heliyon.2024.e37554. eCollection 2024 Sep 30. Heliyon. 2024. PMID: 39309810 Free PMC article. - Divergent Evolution in Bilateral Prostate Cancer: a Case Study.
Haas R, Patel Y, Liu LY, Huang RR, Weiner A, Yamaguchi TN, Agrawal R, Boutros PC, Reiter RE. Haas R, et al. medRxiv [Preprint]. 2024 Aug 23:2024.08.22.24312320. doi: 10.1101/2024.08.22.24312320. medRxiv. 2024. PMID: 39228741 Free PMC article. Preprint. - Digital spatial profiling identifies the tumor center as a topological niche in prostate cancer characterized by an upregulation of BAD.
Huber AK, Kaczorowski A, Schneider F, Böning S, Görtz M, Langhoff D, Schwab C, Stenzinger A, Hohenfellner M, Duensing A, Duensing S. Huber AK, et al. Sci Rep. 2024 Aug 31;14(1):20281. doi: 10.1038/s41598-024-71070-6. Sci Rep. 2024. PMID: 39217197 Free PMC article. - Tumor evolution metrics predict recurrence beyond 10 years in locally advanced prostate cancer.
Fernandez-Mateos J, Cresswell GD, Trahearn N, Webb K, Sakr C, Lampis A, Stuttle C, Corbishley CM, Stavrinides V, Zapata L, Spiteri I, Heide T, Gallagher L, James C, Ramazzotti D, Gao A, Kote-Jarai Z, Acar A, Truelove L, Proszek P, Murray J, Reid A, Wilkins A, Hubank M, Eeles R, Dearnaley D, Sottoriva A. Fernandez-Mateos J, et al. Nat Cancer. 2024 Sep;5(9):1334-1351. doi: 10.1038/s43018-024-00787-0. Epub 2024 Jul 12. Nat Cancer. 2024. PMID: 38997466 Free PMC article. - The COMPASS complex maintains the metastatic capacity imparted by a subpopulation of cells in UPS.
Ban GI, Puviindran V, Xiang Y, Nadesan P, Tang J, Ou J, Guardino N, Nakagawa M, Browne M, Wallace A, Ishikawa K, Shimada E, Martin JT, Diao Y, Kirsch DG, Alman BA. Ban GI, et al. iScience. 2024 Jun 5;27(7):110187. doi: 10.1016/j.isci.2024.110187. eCollection 2024 Jul 19. iScience. 2024. PMID: 38989451 Free PMC article.
References
- Eur Urol. 2013 Feb;63(2):347-53 - PubMed
- Nature. 2012 Sep 6;489(7414):91-100 - PubMed
- J Pathol. 1996 Nov;180(3):295-9 - PubMed
- Nature. 2011 Feb 10;470(7333):214-20 - PubMed
- BMJ. 2010 Sep 14;341:c4543 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous